Home
Categories
EXPLORE
True Crime
Society & Culture
Comedy
History
Business
Music
Education
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/44/76/6a/44766a4c-7495-de55-f956-98bf47a79da4/mza_7129400420082630014.jpg/600x600bb.jpg
Post-Hoc Live
Endpoints News
28 episodes
6 days ago
Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations. Subscribe to Endpoints and the Post-Hoc newsletter here: https://profile.endpoints.news/create-account. Send us an email at: posthoclive@endpointsnews.com
Show more...
News
RSS
All content for Post-Hoc Live is the property of Endpoints News and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations. Subscribe to Endpoints and the Post-Hoc newsletter here: https://profile.endpoints.news/create-account. Send us an email at: posthoclive@endpointsnews.com
Show more...
News
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43803961/43803961-1748957343158-e4d9415936a7a.jpg
Is China a threat, or an investment opportunity? Post-Hoc Live with Curie.Bio CEO Zach Weinberg
Post-Hoc Live
42 minutes 32 seconds
4 months ago
Is China a threat, or an investment opportunity? Post-Hoc Live with Curie.Bio CEO Zach Weinberg

Biopharma companies are increasingly turning to China to find new molecules, and looking to Chinese companies for licensing deals. Some investors are leaning in — but others, like Curie.Bio CEO Zach Weinberg, think they should stay away.This week, Weinberg joins Post-Hoc Live to help us to take stock of the landscape. Be sure to check out our coverage before you tune in: https://endpoints.news/us-investors-divided-on-chinas-biotech-rise/

Post-Hoc Live
Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations. Subscribe to Endpoints and the Post-Hoc newsletter here: https://profile.endpoints.news/create-account. Send us an email at: posthoclive@endpointsnews.com